|
|
||||||||
Receptors1
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322
Fc
Rs with the ITIM domain have been shown to regulate the inflammatory signal delivered by the ITAM-containing Fc
Rs. In this study, we demonstrate that the function of human neutrophil Fc
R type IIA (CD32A) is regulated in a distinct manner by different cell activation signals at the ligand-binding stage. Activation of neutrophils with fMLP up-regulated the ligand-binding function of CD32A, whereas PMA-mediated activation completely abolished ligand binding without altering CD32A expression. Furthermore, PMA treatment also abolished CD16B-dependent ligand binding irrespective of the level of expression. The effect of PMA was cell type specific, because the ligand-binding function of CD32A expressed on cultured cells such as K562 and CHO-CD32A transfectants was not affected by PMA. Interestingly, phorbol 12,13-dibutyrate, another phorbol ester, and IL-8 up-regulated CD32A-dependent ligand-binding function. These results demonstrate that regulation of CD32A-dependent ligand binding in human neutrophils is not only cell type specific but also activation signal specific. Moreover, these results suggest the possibility that signals delivered to neutrophils by various inflammatory stimuli can exert opposing effects on the function of human Fc
Rs, representing a novel inside-out regulatory mechanism of Fc
R ligand binding.
This article has been cited by other articles:
![]() |
E. Garcia-Garcia, G. Nieto-Castaneda, M. Ruiz-Saldana, N. Mora, and C. Rosales Fc{gamma}RIIA and Fc{gamma}RIIIB Mediate Nuclear Factor Activation through Separate Signaling Pathways in Human Neutrophils J. Immunol., April 15, 2009; 182(8): 4547 - 4556. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Benitez-Ribas, P. Tacken, C. J. A. Punt, I. J. M. de Vries, and C. G. Figdor Activation of Human Plasmacytoid Dendritic Cells by TLR9 Impairs Fc{gamma}RII-Mediated Uptake of Immune Complexes and Presentation by MHC Class II J. Immunol., October 15, 2008; 181(8): 5219 - 5224. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. J. Florey, M. Johns, O. O. Esho, J. C. Mason, and D. O. Haskard Antiendothelial cell antibodies mediate enhanced leukocyte adhesion to cytokine-activated endothelial cells through a novel mechanism requiring cooperation between Fc{gamma}RIIa and CXCR1/2 Blood, May 1, 2007; 109(9): 3881 - 3889. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |